After ischemic stroke in patients receiving aspirin, switching to another antithrombotic regimen does not reduce recurrence

Key Points

• To determine if switching from aspirin to another antithrombotic regimen reduces the recurrence of ischemic stroke.
• Observational analysis of ischemic stroke patients
• Comparison of antithrombotic regimens
• Assessment of recurrence rates
• No significant reduction in stroke recurrence after switching regimens
• Stable recurrence rates observed among patients on aspirin
• Implications for antithrombotic management following ischemic stroke

Abstract